LY2608204

CAS No. 1234703-40-2

LY2608204( LY-2608204 | LY 2608204 | LY2608204 )

Catalog No. M17209 CAS No. 1234703-40-2

LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 86 In Stock
2MG 43 In Stock
5MG 69 In Stock
10MG 93 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LY2608204
  • Note
    Research use only, not for human use.
  • Brief Description
    LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
  • Description
    LY-2608204 is an activator of glucokinase (GK) with an EC50 value of 42 nM. LY2608204 decreases plasma glucose in a dose-dependent manner at both fasted and postprandial glucose levels. In 2010, LY-2608204 was entered clinical trials in Patients With Type 2 Diabetes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    LY-2608204 | LY 2608204 | LY2608204
  • Pathway
    Neuroscience
  • Target
    GluR
  • Recptor
    glucokinase
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1234703-40-2
  • Formula Weight
    559.81
  • Molecular Formula
    C28H37N3O3S3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 100 mg/mL. 178.63 mM
  • SMILES
    C1CCC(CC1)[C@@H]1C[C@]1(C(=O)Nc1ncc(s1)SCCN1CCCC1)c1ccc(cc1)S(=O)(=O)C1CC1
  • Chemical Name
    (1R,2S)-2-cyclohexyl-1-(4-cyclopropylsulfonylphenyl)-N-[5-(2-pyrrolidin-1-ylethylsulfanyl)-1,3-thiazol-2-yl]cyclopropane-1-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Chelidamic acid

    Chelidamic acid is a heterocyclic organic acid with a pyran skeleton. Chelidamic acid is inhibitors of glutamate decarboxylase with a Ki of 33 μM.

  • Cutamesine dihydroch...

    Cutamesine dihydrochloride is a selective?σ1 receptor agonist (IC50: 17.4 nM).

  • AZ-33

    AZ-33 is an LDHA inhibitor. Binding affinity to 6-His-tagged human LDHA (2 to 322 amino acid residue) expressed in Escherichia coli BL21 (DE3) cells by SPR analysis with an active value of 0.093 μM.